AnGes Inc (AMGXF)
0.4087
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
AnGes Gross Profit Margin (Quarterly): 31.07% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 31.07% |
| June 30, 2024 | 32.54% |
| March 31, 2024 | 63.05% |
| December 31, 2023 | 14.39% |
| September 30, 2023 | 37.55% |
| June 30, 2023 | 4.17% |
| March 31, 2023 | -51.51% |
| December 31, 2022 | 3.32% |
| September 30, 2022 | -161.8% |
| June 30, 2022 | -23.01% |
| March 31, 2022 | -6.82% |
| December 31, 2021 | 11.70% |
| September 30, 2021 | -19.33% |
| June 30, 2021 | 40.16% |
| March 31, 2021 | 40.18% |
| December 31, 2020 | 40.59% |
| September 30, 2020 | 40.10% |
| June 30, 2020 | 48.21% |
| March 31, 2020 | 39.75% |
| December 31, 2019 | 17.19% |
| September 30, 2019 | 99.24% |
| June 30, 2019 | 50.76% |
| March 31, 2019 | 52.39% |
| December 31, 2018 | 84.28% |
| September 30, 2018 | 50.76% |
| Date | Value |
|---|---|
| June 30, 2018 | 50.92% |
| March 31, 2018 | 51.00% |
| December 31, 2017 | 51.04% |
| September 30, 2017 | 51.20% |
| June 30, 2017 | 51.39% |
| March 31, 2017 | 51.41% |
| December 31, 2016 | 82.50% |
| September 30, 2016 | 49.45% |
| June 30, 2016 | 49.87% |
| March 31, 2016 | 49.25% |
| December 31, 2015 | 52.94% |
| September 30, 2015 | 48.57% |
| June 30, 2015 | 68.06% |
| March 31, 2015 | 55.71% |
| December 31, 2014 | 93.25% |
| September 30, 2014 | 61.86% |
| June 30, 2014 | 56.04% |
| March 31, 2014 | 67.03% |
| December 31, 2013 | 58.32% |
| September 30, 2013 | 53.14% |
| June 30, 2013 | 84.15% |
| March 31, 2013 | 81.11% |
| December 31, 2012 | 39.14% |
| September 30, 2012 | 58.44% |
| June 30, 2012 | 88.45% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-161.8%
Minimum
Sep 2022
63.05%
Maximum
Mar 2024
10.07%
Average
24.13%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 66.47% |
| Nxera Pharma Co Ltd | 78.44% |
| PeptiDream Inc | 89.26% |
| Healios KK | 86.35% |
| SanBio Co Ltd | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.74% |
| Return on Assets | -32.96% |
| Return on Invested Capital | -37.32% |
| Profit Margin (Quarterly) | -2.95K% |
| Operating Margin (Quarterly) | -1.56K% |
| Return on Net Operating Assets | -38.80% |